GGrantIndex
Sort

50,496 grants matching lung cancer

iPSC-based blood regenerative therapies for AIDS

$694,457
Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2017 · HL

iPSC-based blood regenerative therapies for AIDS

$694,457
Igor I Slukvin · University Of Wisconsin-Madison · R01 · FY2016 · HL

Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases

$694,319
Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2021 · CA

T cell homeostasis

$694,309
Stephen C Jameson · University Of Minnesota · R01 · FY2019 · AI

Characterization of Potential Harm Caused by Electronic Cigarette Flavor Chemicals and their Reaction Products

$694,308
Prudence Talbot · University Of California Riverside · R01 · FY2020 · ES

The NYU Women's Health Study

$694,206
Anne Zeleniuch-Jacquotte · New York University School Of Medicine · UM1 · FY2017 · CA

Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction

$694,020
Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA

The NYU Women's Health Study

$693,828
Anne Zeleniuch-Jacquotte · New York University School Of Medicine · U01 · FY2020 · CA

Quantifying patient-provider communication using machine learning to assess its impact on metastatic cancer patients' outcomes

$693,804
Samah Jamal Fodeh Jarad · Yale University · R01 · FY2025 · CA

CCR Confocal Microscopy Core

$693,802
Susan Garfield · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers

$693,779
Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2025 · CA

CA: Tissue and Pathology

$693,759
Massimo F Loda · Dana-Farber Cancer Inst · P50 · FY2010 · CA

Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy

$693,716
Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2025 · CA

Investigating disseminated cancer cell clonal cooperation and immune control in dormancy and metastasis

$693,712
Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · U01 · FY2025 · CA

The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center

$693,679
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2014 · CA

Real-time in vivo proton range verification in proton therapy with thallium bromide detectors

$693,569
Gerard Ariã‘o Estrada · University Of California At Davis · R01 · FY2022 · EB

Urban and Reservation Implementation of All Nations Breath of Life to Improve Smoking Cessation Rates among American Indians

$693,503
Christine Makosky Daley · Lehigh University · R01 · FY2021 · DA

Statistical Informatics for Cancer Research

$693,299
Miguel Hernan · Harvard School Of Public Health · P01 · FY2017 · CA

Statistical Informatics for Cancer Research

$693,299
Xihong Lin · Harvard School Of Public Health · P01 · FY2016 · CA

Advanced PET/CT Imaging for Improving Clinical Trials

$693,233
Paul E Kinahan · University Of Washington · U01 · FY2015 · CA

Clinical production of viral vectors for cancer gene therapy

$693,211
Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA

Faith-Based Approaches in the Treatment of Hypertension (FAITH)

$693,067
Gbenga Godwin Ogedegbe · New York University School Of Medicine · R01 · FY2010 · HL

Sex/Gender and Nicotine Addiction: Hormones, Behavior and Neuroimaging

$692,969
Nancy K. Mello · Mclean Hospital · R01 · FY2012 · DA

Social media support groups for adolescent vaping cessation

$692,872
Pamela May Ling · University Of California, San Francisco · R01 · FY2024 · CA

Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial

$692,835
Mona N. Fouad · University Of Alabama At Birmingham · N01 · FY2009 · CA